Septerna, Inc. Common Stock (SEPN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
Septerna, Inc. Common Stock (SEPN) Financials: Revenue, Profit and Cash Flow
Septerna, Inc. Common Stock reported revenue of $45.95M for the fiscal year ended Dec 31, 2025, up 4174.5% from the year before. That year, net income was -$48.88M with a net margin of -106.4%, operating cash flow was $110.19M and free cash flow was $109.67M. The quarter ended Sep 30, 2026 had revenue of $18.88M and net income of -$26.59M.
Revenue and Margins
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $45.95M | +4174.5% | 100.0% | -148.6% | -106.4% |
| Dec 2024 | $1.07M | +611.9% | 100.0% | -7518.4% | -6678.9% |
| Dec 2023 | $151.00K | N/A | 100.0% | 1374.2% | 2768.2% |
| Dec 2022 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | $45.95M | $1.07M | $151.00K | $0 |
| Gross profit | $45.95M | $1.07M | $151.00K | N/A |
| Research and development | $97.58M | $65.34M | $35.98M | $22.04M |
| Operating income | -$68.30M | -$80.82M | $2.08M | -$27.97M |
| Net income | -$48.88M | -$71.80M | $4.18M | -$27.68M |
| EBITDA | N/A | N/A | $2.92M | -$27.39M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.88M | $26.75M | $26.52M | $24.12M | $21.50M | $119.00K | $219.00K | $212.00K | $176.00K | $370.00K | $317.00K | $118.00K |
| Gross profit | $18.88M | $26.75M | $26.52M | $24.12M | $21.50M | $119.00K | $219.00K | $212.00K | $176.00K | $370.00K | $317.00K | $118.00K |
| Operating income | -$27.23M | -$16.84M | -$13.30M | -$16.02M | $2.61M | -$28.98M | -$25.91M | -$24.72M | -$22.55M | -$18.07M | -$15.49M | $34.32M |
| Net income | -$26.59M | -$13.03M | -$8.64M | -$10.74M | $8.17M | -$24.84M | -$21.48M | -$20.67M | -$20.52M | -$16.44M | -$14.17M | $34.89M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $2.21M by $118.51M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Total assets | $596.19M | $456.55M | $130.87M | $36.12M |
| Current assets | $410.96M | $356.82M | $112.68M | $31.89M |
| Cash and equivalents | $120.72M | $238.20M | $88.48M | $30.61M |
| Total liabilities | $214.26M | $36.51M | $20.03M | $80.32M |
| Short-term debt | $2.21M | $1.85M | N/A | $710.00K |
| Shareholder equity | $381.93M | $420.05M | -$38.37M | -$44.20M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $619.40M | $566.74M | $569.69M | $596.19M | $606.65M | $415.23M | $434.02M | $456.55M | $174.28M | $176.63M | N/A | $130.87M |
| Total liabilities | $191.47M | $180.02M | $191.23M | $214.26M | $217.92M | $37.67M | $33.75M | $36.51M | $37.53M | $244.40M | N/A | $169.24M |
| Cash and equivalents | $167.12M | $84.66M | $71.61M | $120.72M | $319.99M | $189.31M | $210.04M | $238.20M | $88.24M | $131.17M | N/A | $88.48M |
| Shareholder equity | $427.93M | $386.72M | $378.46M | $381.93M | $388.73M | $377.56M | $400.27M | $420.05M | -$87.41M | -$67.76M | N/A | -$38.37M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 99.5% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | $110.19M | -$67.47M | -$38.72M | -$23.30M |
| Capital expenditures | $518.00K | $2.10M | $2.88M | $1.29M |
| Free cash flow | $109.67M | -$69.57M | -$41.60M | -$24.59M |
| Share repurchases | N/A | $1.00K | $1.00K | N/A |
| Investing cash flow | -$229.35M | -$160.60M | $22.12M | -$1.29M |
| Financing cash flow | $1.69M | $377.78M | $74.52M | $30.05M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.77M | -$22.18M | -$25.63M | -$14.99M | $168.81M | -$20.29M | -$23.34M | -$20.96M | -$16.81M | -$12.99M | -$16.71M | -$8.80M |
| Capital expenditures | $127.00K | N/A | $832.00K | $65.00K | $13.00K | $58.00K | $382.00K | $612.00K | $578.00K | $149.00K | $764.00K | $1.24M |
| Free cash flow | -$13.89M | N/A | -$26.46M | -$15.05M | $168.79M | -$20.34M | -$23.73M | -$21.57M | -$17.39M | -$13.14M | -$17.48M | -$10.04M |
Frequently Asked Questions About SEPN
What is Septerna, Inc. Common Stock's annual revenue?
Septerna, Inc. Common Stock reported revenue of $45.95M for the fiscal year ended Dec 31, 2025.
How fast is Septerna, Inc. Common Stock's revenue growing?
Revenue was up 4174.5% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is Septerna, Inc. Common Stock profitable?
No. Septerna, Inc. Common Stock reported net income of -$48.88M for the fiscal year ended Dec 31, 2025, with a net margin of -106.4%.
How much free cash flow does SEPN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $110.19M minus capital expenditures of $518.00K produced free cash flow of $109.67M.
How much debt does Septerna, Inc. Common Stock have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $2.21M and cash and equivalents of $120.72M.
SEPN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors